Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT: Dalteparin vs UFH in Critical Care
NCT00182143Phase 3Completed
- Sponsor
- McMaster University
- Start
- May 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of dalteparin in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by McMaster University. Started May 2006; status: completed.
02
Drugs
dalteparin
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00182143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182143.